[Antibodies to thyroglobulin in patients with cancer].
Investigations of over 300 oncological patients and 120 healthy individuals have evidenced a considerable increase in the frequency of detecting antibodies to thyreoglobulin (in the titre 1/80 and higher) in patients with cancer of the breast, sigmoid and stomach in females and a tendency to such increase in cancer of the uterine body, and a number of other localizations.
D000328:Adult; D000367:Age Factors; D001323:Autoantibodies / Q000302:isolation & purification*; D001859:Bone Neoplasms / Q000276:immunology; D001943:Breast Neoplasms / Q000276:immunology; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000276:immunology; D008175:Lung Neoplasms / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000276:immunology*; D010051:Ovarian Neoplasms / Q000276:immunology; D012004:Rectal Neoplasms / Q000276:immunology; D012811:Sigmoid Neoplasms / Q000276:immunology; D012983:Soft Tissue Neoplasms / Q000276:immunology; D013954:Thyroglobulin / Q000276:immunology*; D014594:Uterine Neoplasms / Q000276:immunology
D001323:Autoantibodies; D013954:Thyroglobulin
Antitela k tireoglobulinu u onkologicheskikh bol'nykh.